What Delhi’s coronavirus outbreak can teach us about herd immunity
Large number of Indians thought to have antibodies raising hopes of avoiding a second spike

Almost a quarter of Delhi’s 28 million residents may have coronavirus antibodies, making the Indian capital one of the worst hit cities in the world, research has revealed.
A sample of 20,000 people carried out by India’s National Centre for Disease Control (NCDC) found 23.4% had antibodies to the virus, with the majority of infections appearing to have been asymptomatic.
The pandemic last month hit Delhi hard, “pushing the city’s healthcare system to the brink of collapse” and causing many deaths as “hospitals ran out of beds and ventilators”, The Guardian says.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Latest figures show that India has the third highest number of Covid-19 cases in the world, with 1.2m confirmed infections and numbers rising by more than 40,000 a day.
And the “curve of infections is showing no sign of flattening”, with states across the country reintroducing local lockdowns and curfews in an effort to curb the virus’s spread, the paper adds.
The NCDC study suggests that around 180 million Indians, representing almost 15% of the population, may already have developed Covid-19 antibodies. Experts have heralded the discovery as “proof that India is hurtling towards herd immunity”, India Today says.
“Only around six per cent of Delhi's population tested positive for novel coronavirus, but one-fourth of Delhi got immunity. This is herd immunity. These people have immunity even without getting a vaccine,” Dr SK Sareen, director of the New Delhi-based Institute of Liver and Biliary Sciences, told India Today.
“Even as these self-acquired antibodies are yet to be titrated [measured], their presence means that these people were infected and managed to clear the virus,” Sareen added.
A severe lack of testing across India has been blamed for the wide discrepancy between reported cases and the number of people thought to have antibodies, The Telegraph says.
A senior Indian epidemiologist said the findings were “encouraging and could see its cities reach herd immunity by the end of August”.
“In a few weeks, Delhi will attain herd immunity,” Dr Jayaprakash Muliyil told The Hindu. “There are some questions on how long the immunity lasts. I think it will be a long-lasting immunity, but I cannot give you an exact number.”
Most scientists have said that herd immunity would only be reached when 60-70% of the community are protected against the virus, although recent studies have noted that the infection rarely spreads beyond about 20% of a local population.
However, Delhi’s government has said the doubt about the duration of the immune response means that “containment measures need to continue with the same rigour”. Research conducted in the UK found that patients who have recovered from Covid-19 may “lose their antibodies” to the disease within three months.
Scientists at King’s College London analysed more than 90 patients and healthcare workers at Guy’s and St Thomas’ Hospital, London and found antibodies that can defeat the virus peaked around three weeks after symptoms first appeared, before suddenly declining.
Other researchers have focused on T-cell immunity to Covid-19, which is thought to offer longer-lasting protection.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
May 31 editorial cartoons
Cartoons Saturday's political cartoons include how much to pay for a pardon, medical advice from a brain worm, and a simple solution to the national debt.
-
5 costly cartoons about the national debt
Cartoons Political cartoonists take on the USA's financial hole, rare bipartisan agreement, and Donald Trump and Mike Johnson.
-
Green goddess salad recipe
The Week Recommends Avocado can be the creamy star of the show in this fresh, sharp salad
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain